News
Stories and articles featuring PCI, our partners, and Penn-affiliated spinout companies
New microfluidic device delivers mRNA nanoparticles a hundred times faster
With a ‘liquid assembly line,’ Penn researchers have produced mRNA-delivering-nanoparticles significantly faster than standard microfluidic technologies.
Penn I-Corps completed two successful cohorts during FY21 with 22 different teams
A look at I-Corps in FY21
PCI and Pennovation Center sponsor Philly Tech Week and PACT Capital Conference
Along with the Penn Emerging Startup pitch session, PCI and the Pennovation Center sponsored Philly Tech Week with financial and marketing support.
PCI programming goes virtual
Throughout FY21, the PCI full suite of programming from I-Corps and Fellows training to our speaker series, were hosted entirely online.
Neuralert achieves a key milestone
Neuralert is developing a novel invention that addresses the problem of late or undetected stroke in hospitalized patients.
Verismo launches with CAR-T expert co-founders
Verismo, a new cell therapy company pioneering multi-chain CAR-T technology, raised $16 million in equity financing.
G2Bio launches with $200M to invest in research and development of novel gene therapies
The G2 Bio Companies, founded by James M. Wilson and the late Tachi Yamada, launched with a $200 million investment commitment from the global investment firm Temasek.
School of Veterinary Medicine faculty form a key biotech partnership
Iveric Bio entered into a sponsored research agreement with Drs. Karina Guziewicz and William Beltran both from the School of Veterinary Medicine.